The World Health Organization says it has cleared the Pfizer-BioNTech coronfirus vaccine for emergency use, giving poor countries access to the image already available in Europe and America North.
All countries with a drug control body must provide their own permit for any COVID-19 vaccine, but countries with weak systems usually rely on WHO to study the scenes.
The global body said late Thursday that the decision to issue its first emergency use test for COVID-19 vaccines “opens the door for countries to speed up their own regulatory consent processes to the introduction and administration of vaccines. “
The UN health agency said its review found the Pfizer-BioNTech vaccine, which has already been approved in the United States, Britain, the European Union and a dozen other countries, “meets the criteria. critical measure for safety and efficacy declared by WHO. “
The BioNTech-Pfizer vaccine must be stored at ultra-freezing temperatures, a major obstacle for developing countries where the necessary freezers and reliable electricity supply will not be available.
“This requirement makes the vaccine more challenging to use in situations where ultra-cold chain equipment is not available or reliably accessible,” the WHO said, adding that it was “working to support allow countries to evaluate their delivery plans and prepare for their use where possible. “
This story was published from a wire group group with no text changes. Only the headline has changed.